In a randomized , open-label , @-way crossover study , subjects received a randomized sequence of SC ondansetron @ mg + rHuPH@ , or ondansetron monotherapy IM ( @ mg ) , IV ( @ mg ) , or PO ( @ mg ) , over @ daily visits .